New drugs developed as anticancer therapy have focused on targeting molecules essential to tumor growth and survival. In particular, protein kinases have emerged as key regulators of all aspects of cancer. Agents that inhibit the activity of cell membrane receptor tyrosine kinases, such as the human
No takes yet. Share an insight, caveat, or question.
Susan Goodin (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: